ID   LIAS_HUMAN              Reviewed;         372 AA.
AC   O43766; A8K873; C9JCF6; Q8IV62;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 3.
DT   12-APR-2017, entry version 144.
DE   RecName: Full=Lipoyl synthase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03123};
DE            EC=2.8.1.8 {ECO:0000255|HAMAP-Rule:MF_03123};
DE   AltName: Full=Lipoate synthase {ECO:0000255|HAMAP-Rule:MF_03123};
DE            Short=LS {ECO:0000255|HAMAP-Rule:MF_03123};
DE            Short=Lip-syn {ECO:0000255|HAMAP-Rule:MF_03123};
DE   AltName: Full=Lipoic acid synthase {ECO:0000255|HAMAP-Rule:MF_03123};
DE   Flags: Precursor;
GN   Name=LIAS {ECO:0000255|HAMAP-Rule:MF_03123}; Synonyms=LAS;
GN   ORFNames=HUSSY-01;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 260-372 (ISOFORM 1).
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B.,
RA   Cannata N., Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to
RT   yeast sequences.";
RL   Yeast 18:69-80(2001).
RN   [6]
RP   VARIANT HGCLAS HIS-249.
RX   PubMed=22152680; DOI=10.1016/j.ajhg.2011.11.011;
RA   Mayr J.A., Zimmermann F.A., Fauth C., Bergheim C., Meierhofer D.,
RA   Radmayr D., Zschocke J., Koch J., Sperl W.;
RT   "Lipoic acid synthetase deficiency causes neonatal-onset epilepsy,
RT   defective mitochondrial energy metabolism, and glycine elevation.";
RL   Am. J. Hum. Genet. 89:792-797(2011).
CC   -!- FUNCTION: Catalyzes the radical-mediated insertion of two sulfur
CC       atoms into the C-6 and C-8 positions of the octanoyl moiety bound
CC       to the lipoyl domains of lipoate-dependent enzymes, thereby
CC       converting the octanoylated domains into lipoylated derivatives.
CC       {ECO:0000255|HAMAP-Rule:MF_03123}.
CC   -!- CATALYTIC ACTIVITY: Protein N(6)-(octanoyl)lysine + 2 sulfur-
CC       (sulfur carrier) + 2 S-adenosyl-L-methionine + 2 reduced [2Fe-2S]
CC       ferredoxin = protein N(6)-(lipoyl)lysine + 2 (sulfur carrier) + 2
CC       L-methionine + 2 5'-deoxyadenosine + 2 oxidized [2Fe-2S]
CC       ferredoxin. {ECO:0000255|HAMAP-Rule:MF_03123}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03123};
CC       Note=Binds 2 [4Fe-4S] clusters per subunit. One cluster is
CC       coordinated with 3 cysteines and an exchangeable S-adenosyl-L-
CC       methionine. {ECO:0000255|HAMAP-Rule:MF_03123};
CC   -!- PATHWAY: Protein modification; protein lipoylation via endogenous
CC       pathway; protein N(6)-(lipoyl)lysine from octanoyl-[acyl-carrier-
CC       protein]: step 2/2. {ECO:0000255|HAMAP-Rule:MF_03123}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255|HAMAP-
CC       Rule:MF_03123}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O43766-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43766-2; Sequence=VSP_047380, VSP_047381;
CC         Note=Gene prediction based on EST data.;
CC       Name=3;
CC         IsoId=O43766-3; Sequence=VSP_054764;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- DISEASE: Hyperglycinemia, lactic acidosis, and seizures (HGCLAS)
CC       [MIM:614462]: An enzymatic defect resulting in an autosomal
CC       recessive disorder of mitochondrial metabolism. It is
CC       characterized by early-onset lactic acidosis, severe
CC       encephalomyopathy, and a pyruvate oxidation defect. Affected
CC       individuals have neonatal-onset epilepsy, poor growth, psychomotor
CC       retardation, muscular hypotonia, lactic acidosis, and elevated
CC       glycine concentration in plasma and urine.
CC       {ECO:0000269|PubMed:22152680}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the radical SAM superfamily. Lipoyl
CC       synthase family. {ECO:0000255|HAMAP-Rule:MF_03123}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK292238; BAF84927.1; -; mRNA.
DR   EMBL; AC021148; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW92932.1; -; Genomic_DNA.
DR   EMBL; BC023635; AAH23635.1; -; mRNA.
DR   EMBL; AJ224162; CAA11859.1; -; mRNA.
DR   CCDS; CCDS3453.1; -. [O43766-1]
DR   CCDS; CCDS3454.1; -. [O43766-2]
DR   CCDS; CCDS63950.1; -. [O43766-3]
DR   RefSeq; NP_001265519.1; NM_001278590.1. [O43766-3]
DR   RefSeq; NP_001265520.1; NM_001278591.1.
DR   RefSeq; NP_001265521.1; NM_001278592.1.
DR   RefSeq; NP_006850.2; NM_006859.3. [O43766-1]
DR   RefSeq; NP_919433.1; NM_194451.2. [O43766-2]
DR   UniGene; Hs.550502; -.
DR   ProteinModelPortal; O43766; -.
DR   SMR; O43766; -.
DR   STRING; 9606.ENSP00000261434; -.
DR   DrugBank; DB00166; Lipoic Acid.
DR   iPTMnet; O43766; -.
DR   PhosphoSitePlus; O43766; -.
DR   EPD; O43766; -.
DR   MaxQB; O43766; -.
DR   PaxDb; O43766; -.
DR   PeptideAtlas; O43766; -.
DR   PRIDE; O43766; -.
DR   TopDownProteomics; O43766-2; -. [O43766-2]
DR   DNASU; 11019; -.
DR   Ensembl; ENST00000261434; ENSP00000261434; ENSG00000121897. [O43766-1]
DR   Ensembl; ENST00000340169; ENSP00000340676; ENSG00000121897. [O43766-2]
DR   Ensembl; ENST00000381846; ENSP00000371270; ENSG00000121897. [O43766-3]
DR   GeneID; 11019; -.
DR   KEGG; hsa:11019; -.
DR   UCSC; uc003guf.5; human. [O43766-1]
DR   CTD; 11019; -.
DR   DisGeNET; 11019; -.
DR   GeneCards; LIAS; -.
DR   HGNC; HGNC:16429; LIAS.
DR   HPA; HPA018842; -.
DR   HPA; HPA019076; -.
DR   MalaCards; LIAS; -.
DR   MIM; 607031; gene.
DR   MIM; 614462; phenotype.
DR   neXtProt; NX_O43766; -.
DR   OpenTargets; ENSG00000121897; -.
DR   Orphanet; 401859; Lipoic acid synthetase deficiency.
DR   PharmGKB; PA30369; -.
DR   eggNOG; KOG2672; Eukaryota.
DR   eggNOG; COG0320; LUCA.
DR   GeneTree; ENSGT00390000006234; -.
DR   HOGENOM; HOG000235998; -.
DR   HOVERGEN; HBG023328; -.
DR   InParanoid; O43766; -.
DR   KO; K03644; -.
DR   OMA; EFLQNGP; -.
DR   OrthoDB; EOG091G0AXJ; -.
DR   PhylomeDB; O43766; -.
DR   TreeFam; TF300817; -.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   UniPathway; UPA00538; UER00593.
DR   GenomeRNAi; 11019; -.
DR   PRO; PR:O43766; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000121897; -.
DR   CleanEx; HS_LIAS; -.
DR   ExpressionAtlas; O43766; baseline and differential.
DR   Genevisible; O43766; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0016992; F:lipoate synthase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0009107; P:lipoate biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; ISS:UniProtKB.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00206; Lipoyl_synth; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR006638; Elp3/MiaB/NifB.
DR   InterPro; IPR031691; LIAS_N.
DR   InterPro; IPR003698; Lipoyl_synth.
DR   InterPro; IPR007197; rSAM.
DR   PANTHER; PTHR10949; PTHR10949; 1.
DR   Pfam; PF16881; LIAS_N; 1.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   PIRSF; PIRSF005963; Lipoyl_synth; 1.
DR   SFLD; SFLDG01058; lipoyl_synthase_like; 1.
DR   SMART; SM00729; Elp3; 1.
DR   TIGRFAMs; TIGR00510; lipA; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Alternative splicing; Complete proteome; Disease mutation;
KW   Iron; Iron-sulfur; Metal-binding; Mitochondrion; Reference proteome;
KW   S-adenosyl-L-methionine; Transferase; Transit peptide.
FT   TRANSIT       1     27       Mitochondrion. {ECO:0000255|HAMAP-
FT                                Rule:MF_03123}.
FT   CHAIN        28    372       Lipoyl synthase, mitochondrial.
FT                                /FTId=PRO_0000017723.
FT   METAL       106    106       Iron-sulfur 1 (4Fe-4S).
FT                                {ECO:0000255|HAMAP-Rule:MF_03123}.
FT   METAL       111    111       Iron-sulfur 1 (4Fe-4S).
FT                                {ECO:0000255|HAMAP-Rule:MF_03123}.
FT   METAL       117    117       Iron-sulfur 1 (4Fe-4S).
FT                                {ECO:0000255|HAMAP-Rule:MF_03123}.
FT   METAL       137    137       Iron-sulfur 2 (4Fe-4S-S-AdoMet).
FT                                {ECO:0000255|HAMAP-Rule:MF_03123}.
FT   METAL       141    141       Iron-sulfur 2 (4Fe-4S-S-AdoMet).
FT                                {ECO:0000255|HAMAP-Rule:MF_03123}.
FT   METAL       144    144       Iron-sulfur 2 (4Fe-4S-S-AdoMet).
FT                                {ECO:0000255|HAMAP-Rule:MF_03123}.
FT   VAR_SEQ     203    245       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054764.
FT   VAR_SEQ     320    322       EEY -> NFS (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_047380.
FT   VAR_SEQ     323    372       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_047381.
FT   VARIANT     249    249       R -> H (in HGCLAS; dbSNP:rs144133667).
FT                                {ECO:0000269|PubMed:22152680}.
FT                                /FTId=VAR_067839.
FT   CONFLICT    253    253       A -> V (in Ref. 4; AAH23635).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       R -> G (in Ref. 5; CAA11859).
FT                                {ECO:0000305}.
SQ   SEQUENCE   372 AA;  41911 MW;  A5BEACA1F36CEB74 CRC64;
     MSLRCGDAAR TLGPRVFGRY FCSPVRPLSS LPDKKKELLQ NGPDLQDFVS GDLADRSTWD
     EYKGNLKRQK GERLRLPPWL KTEIPMGKNY NKLKNTLRNL NLHTVCEEAR CPNIGECWGG
     GEYATATATI MLMGDTCTRG CRFCSVKTAR NPPPLDASEP YNTAKAIAEW GLDYVVLTSV
     DRDDMPDGGA EHIAKTVSYL KERNPKILVE CLTPDFRGDL KAIEKVALSG LDVYAHNVET
     VPELQSKVRD PRANFDQSLR VLKHAKKVQP DVISKTSIML GLGENDEQVY ATMKALREAD
     VDCLTLGQYM QPTRRHLKVE EYITPEKFKY WEKVGNELGF HYTASGPLVR SSYKAGEFFL
     KNLVAKRKTK DL
//
